{
  "trial_id": "NCT01743001",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, resting peripheral oxygen saturation (SpO2), mean resting pulmonary arterial pressure (mPAP), pulmonary capillary wedge pressure (PCWP), pulmonary vascular resistance (PVR), WHO functional class, 6-minute walk test (6MWT) distance, presence of Down Syndrome, type of congenital shunting defect (e.g., ASD, VSD, AVSD, PDA, AP window, TAPVR, PAPVR), previous surgical palliation status, total lung capacity (TLC), forced expiratory volume in one second (FEV1), forced vital capacity (FVC), treatment with prostanoids, treatment with PDE-5 inhibitors, treatment with endothelin receptor antagonists (ERAs), treatment with diuretics, consideration for organ transplant.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "WHO functional class",
          "WHO functional class"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "resting peripheral oxygen saturation (SpO2)",
        "mean resting pulmonary arterial pressure (mPAP)",
        "pulmonary capillary wedge pressure (PCWP)",
        "pulmonary vascular resistance (PVR)",
        "6-minute walk test (6MWT) distance",
        "presence of Down Syndrome",
        "type of congenital shunting defect (e.g., ASD, VSD, AVSD, PDA, AP window, TAPVR, PAPVR)",
        "previous surgical palliation status",
        "total lung capacity (TLC)",
        "forced expiratory volume in one second (FEV1)",
        "forced vital capacity (FVC)",
        "treatment with prostanoids",
        "treatment with PDE-5 inhibitors",
        "treatment with endothelin receptor antagonists (ERAs)",
        "treatment with diuretics",
        "consideration for organ transplant"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline 6-minute Walk Distance (6MWD), Resting peripheral oxygen saturation (SpO2), Mean resting pulmonary arterial pressure (mPAP), Pulmonary capillary wedge pressure (PCWP), Pulmonary vascular resistance (PVR), WHO functional class, Type of congenital heart defect,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "WHO functional class",
          "WHO functional class"
        ]
      ],
      "remaining_reference_features": [
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Baseline 6-minute Walk Distance (6MWD)",
        "Resting peripheral oxygen saturation (SpO2)",
        "Mean resting pulmonary arterial pressure (mPAP)",
        "Pulmonary capillary wedge pressure (PCWP)",
        "Pulmonary vascular resistance (PVR)",
        "Type of congenital heart defect"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, WHO Functional Class, 6-minute Walk Distance, Pulmonary Arterial Pressure, Pulmonary Vascular Resistance, Oxygen Saturation.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ],
        [
          "WHO functional class",
          "WHO Functional Class"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "6-minute Walk Distance",
        "Pulmonary Arterial Pressure",
        "Pulmonary Vascular Resistance",
        "Oxygen Saturation"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, height, body mass index (BMI), ethnicity, Down Syndrome status, WHO functional class, resting peripheral oxygen saturation (SpO2), mean resting pulmonary arterial pressure (mPAP), pulmonary capillary wedge pressure (PCWP) or mean left atrial pressure (LAP) or left ventricular end diastolic pressure (LVED), pulmonary vascular resistance (PVR), 6-minute walk distance (6MWD) at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "WHO functional class",
          "WHO functional class"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "ethnicity",
        "Down Syndrome status",
        "resting peripheral oxygen saturation (SpO2)",
        "mean resting pulmonary arterial pressure (mPAP)",
        "pulmonary capillary wedge pressure (PCWP) or mean left atrial pressure (LAP) or left ventricular end diastolic pressure (LVED)",
        "pulmonary vascular resistance (PVR)",
        "6-minute walk distance (6MWD) at baseline."
      ]
    }
  }
}